Compare MUX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MUX | INMD |
|---|---|---|
| Founded | 1979 | 2008 |
| Country | Canada | Israel |
| Employees | 1432 | 660 |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 861.7M |
| IPO Year | N/A | 2018 |
| Metric | MUX | INMD |
|---|---|---|
| Price | $26.02 | $13.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $23.38 | $16.75 |
| AVG Volume (30 Days) | 877.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.01 | $3.80 |
| Revenue Next Year | $45.01 | $4.79 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.38 | $13.16 |
| 52 Week High | $29.70 | $19.78 |
| Indicator | MUX | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.56 | 38.00 |
| Support Level | $22.96 | $13.28 |
| Resistance Level | $27.33 | $14.80 |
| Average True Range (ATR) | 1.49 | 0.32 |
| MACD | -0.14 | -0.12 |
| Stochastic Oscillator | 50.17 | 12.94 |
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.